跳至主要内容
临床试验/CTRI/2023/01/049325
CTRI/2023/01/049325尚未招募未知

EFFECT OF LEVETIRACETAM AND SODIUM VALPROATE MONOTHERAPY ON SERUM 25-HYDROXY VITAMIN D, SERUM CALCIUM , SERUM PHOSPHATE AND SERUM ALKALINE PHOSPHATE LEVELS IN PEDIATRIC EPILEPTIC PATIENTS IN TERTIARY CARE HOSPITAL,HALDWANI, UTTRAKHAND

Dr Yashi Gupta0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. All newly diagnosed patients (age- 1 to 16 years) of epilepsy coming to pediatrics OPD and pediatric ward who will be initiated on sodium valproate or levetiracetam monotherapy
  • 2. Patientâ??s parents who have given written informed consent. Assent from children more than 9 years of age if feasible (conscious and oriented child with normal intelligence).

排除标准

  • EXCLUSION CRITERIA
  • 1. Children with episode of febrile convulsion
  • 2.Epileptic children who are seizure free and had stopped taking medication for 3 or more years
  • 3.Children on vitamin D supplementation
  • 4.Children with metabolic bone disease.
  • 5.Children with significant renal, hepatic, endocrine disorders which will effect vitamin D and calcium metabolism.
  • 6. Patients with epilepsy who are on antiepileptic polytherapy.
  • 7.Patients who are in need of critical care and are bed ridden

研究者

发起方
Dr Yashi Gupta

相似试验